Contact
searchSearch
HMP Global

Medication Safety Topic Center

Featured Article

Poll
Pharmacy Benefit Managers vs Independent Pharmacies
03/25/2024
03/25/2024
Pharmacy Learning Network
Quiz
Reviewing the Stop Dangerous Pharmacies Act
03/07/2024
What is the Stop Dangerous Pharmacies Act?
What is the Stop Dangerous Pharmacies Act?
What is the Stop Dangerous...
03/07/2024
Pharmacy Learning Network
News
Global GLP-1 Agonist Market Trends
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
Poll
Ensuring Safe and Effective Use of Weight Loss Drugs
03/01/2024
03/01/2024
Pharmacy Learning Network
News
Subpotent Eye Solution Recalled
09/21/2023
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries...
09/21/2023
Pharmacy Learning Network
News
Homeopathic Products Pulled
07/07/2023
Jolynn Tumolo
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products...
07/07/2023
Pharmacy Learning Network
News
Opioid Analgesic Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Antifungal Injection Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Label/Capsule Mix-Up Prompts Recall
06/30/2023
Jolynn Tumolo
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to...
06/30/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Hand Sanitizers
06/23/2023
Jolynn Tumolo
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued...
06/23/2023
Pharmacy Learning Network
News
Anticonvulsant Capsules Recalled
06/23/2023
Jolynn Tumolo
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been...
06/23/2023
Pharmacy Learning Network

Newsfeed

News
Global GLP-1 Agonist Market Trends
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
News
Subpotent Eye Solution Recalled
09/21/2023
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries...
09/21/2023
Pharmacy Learning Network
News
Homeopathic Products Pulled
07/07/2023
Jolynn Tumolo
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products...
07/07/2023
Pharmacy Learning Network
News
Opioid Analgesic Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Antifungal Injection Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Label/Capsule Mix-Up Prompts Recall
06/30/2023
Jolynn Tumolo
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to...
06/30/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Hand Sanitizers
06/23/2023
Jolynn Tumolo
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued...
06/23/2023
Pharmacy Learning Network
News
Anticonvulsant Capsules Recalled
06/23/2023
Jolynn Tumolo
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been...
06/23/2023
Pharmacy Learning Network
News
Antifibrinolytic Drug Recalled
06/23/2023
Jolynn Tumolo
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two...
06/23/2023
Pharmacy Learning Network
News
Injection Recalled After Manufacturer Halts Quality Program
06/16/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been...
06/16/2023
Pharmacy Learning Network
News
Albuterol Sulfate Inhalation Solution Recalled for Illegible Labeling
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for albuterol sulfate inhalation solution due to illegible labeling, affecting more than 146 000 unit-dose vials used in respiratory care.
The US Food and Drug Administration (FDA) has issued a Class II recall for albuterol sulfate inhalation solution due to illegible labeling, affecting more than 146 000 unit-dose vials used in respiratory care.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
News
Epinephrine Injection Recalled for Lack of Sterility Assurance
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for epinephrine injection due to sterility assurance concerns, affecting more than 80 000 units used in emergency care settings.
The US Food and Drug Administration (FDA) has issued a Class II recall for epinephrine injection due to sterility assurance concerns, affecting more than 80 000 units used in emergency care settings.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
News
Cipla Cinacalcet Tablets Recalled for Nitrosamine Impurity Above Acceptable Limits
04/16/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Cipla’s cinacalcet tablets due to nitrosamine impurity levels exceeding safety limits, raising concerns for long-term use in dialysis patients.
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Cipla’s cinacalcet tablets due to nitrosamine impurity levels exceeding safety limits, raising concerns for long-term use in dialysis patients.
The US Food and Drug...
04/16/2026
Pharmacy Learning Network
PharmLaw
CMS Proposes Sweeping Prior Authorization Reforms for Drugs, Expanding Transparency and Electronic Requirements
04/15/2026
Hannah Musick
The Centers for Medicare & Medicaid Services has proposed sweeping reforms to modernize prior authorization for drugs, introducing faster decision timelines, expanded electronic requirements, and new transparency measures that could...
The Centers for Medicare & Medicaid Services has proposed sweeping reforms to modernize prior authorization for drugs, introducing faster decision timelines, expanded electronic requirements, and new transparency measures that could...
The Centers for Medicare &...
04/15/2026
Pharmacy Learning Network
News
Xanax XR Tablets Recalled for Dissolution Failure
04/09/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Xanax XR tablets after testing revealed failed dissolution specifications, potentially affecting consistent drug release in patients treated for panic disorder.
The US Food and Drug Administration (FDA) has issued a Class II recall for Xanax XR tablets after testing revealed failed dissolution specifications, potentially affecting consistent drug release in patients treated for panic disorder.
The US Food and Drug...
04/09/2026
Pharmacy Learning Network
News
Cipla Lanreotide Injection Recalled for Lack of Sterility Assurance
04/09/2026
Hannah Musick
A Class II recall is in effect for Cipla’s lanreotide injection prefilled syringes due to sterility assurance concerns tied to manufacturing inspection deficiencies.
A Class II recall is in effect for Cipla’s lanreotide injection prefilled syringes due to sterility assurance concerns tied to manufacturing inspection deficiencies.
A Class II recall is in effect...
04/09/2026
Pharmacy Learning Network
News
Class II Recall for Tramadol Hydrochloride Due to Nitrosamine Impurity Above Specifications
04/09/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for tramadol tablets after stability testing detected a nitrosamine impurity above acceptable limits, raising concerns about long-term exposure.
The US Food and Drug Administration (FDA) has issued a Class II recall for tramadol tablets after stability testing detected a nitrosamine impurity above acceptable limits, raising concerns about long-term exposure.
The US Food and Drug...
04/09/2026
Pharmacy Learning Network
PharmLaw
DOJ Targets Over $500 Million in Health Care and COVID-19 Fraud Schemes Across Multiple Enforcement Actions
04/08/2026
Hannah Musick
The US Department of Justice (DOJ) has launched sweeping enforcement actions targeting over $500 million in alleged fraud across Affordable Care Act (ACA) enrollment, Medicaid drug billing, and COVID-19 relief programs, highlighting...
The US Department of Justice (DOJ) has launched sweeping enforcement actions targeting over $500 million in alleged fraud across Affordable Care Act (ACA) enrollment, Medicaid drug billing, and COVID-19 relief programs, highlighting...
The US Department of Justice...
04/08/2026
Pharmacy Learning Network
News
Macleods Recalls Levothyroxine Sodium Tablets Due to Subpotency
04/02/2026
Hannah Musick
Macleods Pharma USA, Inc is recalling one lot of levothyroxine sodium tablets 150 mcg nationwide after testing identified subpotent drug levels that may reduce therapeutic effectiveness.
Macleods Pharma USA, Inc is recalling one lot of levothyroxine sodium tablets 150 mcg nationwide after testing identified subpotent drug levels that may reduce therapeutic effectiveness.
Macleods Pharma USA, Inc is...
04/02/2026
Pharmacy Learning Network
News
Class II Recall Issued for Poractant Alfa Over Sterility Concerns
04/02/2026
Hannah Musick
Chiesi USA, Inc is recalling select lots of CUROSURF (poractant alfa) intratracheal suspension due to lack of sterility assurance, potentially increasing the risk of contamination in a critical neonatal therapy.
Chiesi USA, Inc is recalling select lots of CUROSURF (poractant alfa) intratracheal suspension due to lack of sterility assurance, potentially increasing the risk of contamination in a critical neonatal therapy.
Chiesi USA, Inc is recalling...
04/02/2026
Pharmacy Learning Network

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
More Evidence of Cardiovascular Harm With NSAIDs
04/13/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of a new study, Dr Jennings advocates for practicing pharmacists to discuss the potential cardiovascular harm associated with short-term use of nonsteroidal anti-inflammatory drugs.
In light of a new study, Dr Jennings advocates for practicing pharmacists to discuss the potential cardiovascular harm associated with short-term use of nonsteroidal anti-inflammatory drugs.
In light of a new study, Dr...
04/13/2023
Pharmacy Learning Network
Commentary
Check Twice, Jab Once: How to Make Sure You Are Administering the Correct Vaccine
03/06/2023
Tyler Nichols, PharmD, BCPS
In this commentary, Tyler Nichols, PharmD, discusses common causes of vaccine errors and shares strategies for reducing risk, including storage best practices, technological solutions, and more.
In this commentary, Tyler Nichols, PharmD, discusses common causes of vaccine errors and shares strategies for reducing risk, including storage best practices, technological solutions, and more.
In this commentary, Tyler...
03/06/2023
Pharmacy Learning Network
Stock image of an open pill bottle with medication spilling out in a pharmacy.
Commentary
Drug Diversion and Leadership Response: Tips for Supporting Staff, Patients
02/01/2023
Sadik Owolewa, PharmD
In this commentary, Sadik Owolewa, PharmD, shares 5 strategies for preventing drug diversion with an emphasis on supporting health care workers, promoting a safe environment, and educating patients.
In this commentary, Sadik Owolewa, PharmD, shares 5 strategies for preventing drug diversion with an emphasis on supporting health care workers, promoting a safe environment, and educating patients.
In this commentary, Sadik...
02/01/2023
Pharmacy Learning Network
Stock image of eye and ear drops.
Commentary
An Eye (Drop) for an Eye, and an Ear (Drop) for an Ear
12/22/2022
Tyler Nichols, PharmD, BCPS
Tyler Nichols, PharmD, BCPS, international safe medication management fellow, Institute for Safe Medication Practices, reviews an incident where ear drops were administered in a patient's eye mistakenly and advises what steps may be taken to...
Tyler Nichols, PharmD, BCPS, international safe medication management fellow, Institute for Safe Medication Practices, reviews an incident where ear drops were administered in a patient's eye mistakenly and advises what steps may be taken to...
Tyler Nichols, PharmD, BCPS,...
12/22/2022
Pharmacy Learning Network
Stock image of a pharmacist holding a prescription and bottle of medication
Commentary
Conflict Management: I Don't Remember Learning This in Pharmacy School
12/14/2022
Jose Nery, PharmD
Jose Nery, PharmD, a 2022-2023 safe medication management fellow with ISMP, shares guidance for pharmacists hoping to better navigate conflict with prescribers while addressing concerns over the safety of an order.
Jose Nery, PharmD, a 2022-2023 safe medication management fellow with ISMP, shares guidance for pharmacists hoping to better navigate conflict with prescribers while addressing concerns over the safety of an order.
Jose Nery, PharmD, a 2022-2023...
12/14/2022
Pharmacy Learning Network
Headshot of Reetu Mukherji, MD, Georgetown University
Interview
Evaluating a Digital Tool for Monitoring Drug Toxicities in Patients With Colorectal Cancer
12/12/2022
Maria Asimopoulos
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD,...
12/12/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Still Seeking Answers for Safe Anticoagulation in Patients on Hemodialysis
12/08/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews a study comparing apixaban to warfarin in patients with atrial fibrillation who received hemodialysis for end-stage kidney disease.
Dr Jennings reviews a study comparing apixaban to warfarin in patients with atrial fibrillation who received hemodialysis for end-stage kidney disease.
Dr Jennings reviews a study...
12/08/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Underutilization of Pharmacists
07/13/2022
Mark A. Munger, PharmD, FCCP, FACC, FHFSA
In the final installment of this series, Dr Munger discusses why pharmacists are uniquely equipped to employ strategies that improve medication safety.  
In the final installment of this series, Dr Munger discusses why pharmacists are uniquely equipped to employ strategies that improve medication safety.  
In the final installment of this...
07/13/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Effective Strategies to Enhance Safety
07/06/2022
Mark A. Munger, PharmD, FCCP, FACC, FHFSA
In the second installment of this series, Dr Munger shares strategies for providers and health systems to improve medication safety.
In the second installment of this series, Dr Munger shares strategies for providers and health systems to improve medication safety.
In the second installment of...
07/06/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Is Hydroxychloroquine Harmful for the Heart?
06/30/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In the latest installment of Talking Therapeutics, Dr Jennings discusses possible adverse events associated with hydroxychloroquine.
In the latest installment of Talking Therapeutics, Dr Jennings discusses possible adverse events associated with hydroxychloroquine.
In the latest installment of...
06/30/2022
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use